SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects
NCT05902962
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinal Dystrophy
PRPF31 Mutationassociated Retinal Dystrophy
RP11
Interventions
DRUG:
VP-001
Sponsor
PYC Therapeutics